@def title = "Publications"

# Publications




Mejzini, R., Flynn, L. L., Pitout, I. L., Fletcher, S., Wilton, S. D., & Akkari, P. A. (2019). [*ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?*](http://doi.org/10.3389/fnins.2019.01310) **Frontiers in Neuroscience**, 13. 

Aung-Htut, M., McIntosh, C., Ham, K., Pitout, I., Flynn, L., Greer, K., … Wilton, S. (2019). [*Systematic Approach to Developing Splice Modulating Antisense Oligonucleotides*](http://dx.doi.org/10.3390/ijms20205030). **International Journal of Molecular Sciences**, 20(20), 5030. 

Pitout, I., Flynn, L. L., Wilton, S. D., & Fletcher, S. (2019). [*Antisense-mediated splice intervention to treat human disease: the odyssey continues*](http://dx.doi.org/10.12688/f1000research.18466.1). **F1000Research**, 8, 710. 

Flynn, L. L., Li, R., Aung-Htut, M. T., Pitout, I. L., Cooper, J. A. L., Hubbard, A., … Fletcher, S. (2018). [*Interaction of modified oligonucleotides with nuclear proteins, formation of novel nuclear structures and sequence-independent effects on RNA processing*](http://dx.doi.org/10.1101/446773). 

Flynn, L. L., Mitrpant, C., Pitout, I. L., Fletcher, S., & Wilton, S. D. (2018). [*Antisense Oligonucleotide-Mediated Terminal Intron Retention of the SMN2 Transcript*](http://dx.doi.org/10.1016/j.omtn.2018.01.011). **Molecular Therapy - Nucleic Acids**, 11, 91–102. 

Pitout, I., Fletcher, S., Etherington, S. and Wilton, S. (2015) [*A spanner in the works of human Transformer-2-β1 autoregulation may reduce the severity of spinal muscular atrophy*](https://researchrepository.murdoch.edu.au/id/eprint/37771/). In: **9th Australasian Gene and Cell Therapy Society meeting**, 29 April - 1 May, Parkville, Victoria, Australia.

Daniels, W. M. U., Pitout, I. L., Afullo, T. J. O., & Mabandla, M. V. (2009). [*The effect of electromagnetic radiation in the mobile phone range on the behaviour of the rat*](https://doi.org/10.1007/s11011-009-9164-3). **Metabolic Brain Disease**, 24(4), 629–641. 